LunaDNA

LunaDNA

Growth Stage

Uniting for the Common Good

Uniting for the Common Good

Overview

Funding data not publicly available
Platform

Self Managed

Start Date

09/27/2022

Close Date

Not Provided

Max. Goal
$2,100,000
Min. Investment

$0

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$30,368,392

Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

High

Location

San Diego, California

Business Type

Growth

LunaDNA is raising funds independently through Reg A+ crowdfunding. The company has built the world’s first and largest database of human health, including genomic and phenotypic data. The business makes the database available to researchers with its members’ consent and facilitates new discoveries, new treatments, and greater predictive power of genomic information. LunaDNA has collaborations with companies, including Genomelink, Genetic Alliance, San Diego Blood Bank, and The University of Vermont Health Network. Joe Beery, Dawn Barry, and Bob Kain founded LunaDNA in 2018. The current crowdfunding campaign has a maximum target of $2.1 million. The campaign proceeds will be used to build the database.

Balance Sheet

Total Assets

$61,978

Accounts Payable & Accrued Liabilities

$19,633

Long Term Debt

$0

Total Liabilities

$332,573

Total Stockholders' Equity

$-270,595

Total Liabilities and Equity

$61,978

Statement of Comprehensive Income Information

Total Revenues

$56,231

Costs & Expenses Applicable to Rev

$205,433

Net Income

$-149,202

Earnings Per Share - Basic

$0.00

Earnings Per Share - Diluted

$0.00

Auditor: Mayer Hoffman McCann P.C.
Financials as of: 09/27/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
LunaDNA 09/27/2023 Self Managed $30,368,392 - Equity - Common Funded RegA+
LunaDNA 09/06/2022 Self Managed $25,787 - Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
LunaDNA on Self Managed 2022
Platform: Self Managed
Security Type: Equity - Common
Valuation: $30,368,392
Price per Share: $1.00

Follow company

Follow LunaDNA on Self Managed 2022

Buy LunaDNA's Deal Report

Warning: according to the close date for this deal, LunaDNA may no longer be accepting investments.

LunaDNA Deal Report

Get KingsCrowd’s comprehensive report on LunaDNA including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether LunaDNA is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the LunaDNA deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge